During the past decade, Cassidy Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cassidy Medical Group" #1 collaborator was "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cassidy Medical Group" are "Acute Migraine" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Cassidy Medical Group" in a lesser frequency.

Most popular intervention types in "Cassidy Medical Group" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cologuard" (1 trials), "Lasmiditan 100 mg" (1 trials), "Lasmiditan 200 mg" (1 trials) and "Placebo (matches lasmiditan doses)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cassidy Medical Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cassidy Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cassidy Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cassidy Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".